However, we did not find a significant difference in the plasma levels of CXCL13 and galectin-9 between patients with different clinical phenotypes (elderly, hepatosplenomegaly, lymphadenopathy), higher LDH concentrations, and WBCs count ≥ 100,000/μL. The gene discussed is CXCL13; the disease is Hepatosplenomegaly.